^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    HPV Selfy

    Company:
    Ulisse BioMed
    Type:
    CE Marked
    Details
    Evidence

    News

    4ms
    The Use of Self-Sampling Devices via a Smartphone Application to Encourage Participation in Cervical Cancer Screening: A Pilot Study. (PubMed, J Clin Med)
    We report an agreement of 93.7% (Cohen's Kappa: 0.798). The study demonstrated the feasibility of HPV-Selfy as a complementary tool in cervical cancer screening, especially where adherence to traditional surveillance is low.
    Journal
    |
    HPV Selfy